<DOC>
	<DOCNO>NCT00068328</DOCNO>
	<brief_summary>RATIONALE : Studying old woman make treatment decision decision affect outcome treatment may help doctor plan effective treatment improve patient quality life . PURPOSE : This clinical trial study patient 's treatment preference decision chemotherapy affect outcome treatment old woman newly diagnose breast cancer .</brief_summary>
	<brief_title>Chemotherapy Decisions Outcomes Older Women With Newly Diagnosed Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine relationship preference chemotherapy decision woman age 65 operable , newly diagnose breast cancer . - Determine factor could target intervention affect relationship preference chemotherapy decision patient . - Determine relationship preference-based chemotherapy decision , quality life , satisfaction treatment decision patient . - Determine disease-free survival compete cause mortality patient . - Determine type physician provider care old breast cancer survivor initial cancer treatment complete explore woman decide physician see . - Measure quality indicator survivorship phase care evaluate quality varies type physician provider model . - Determine long-term patient-reported satisfaction varies function physician model provide follow-up care post-treatment . - Determine whether physician-patient communication coordination care treatment end mediate follow-up quality outcomes post-treatment . OUTLINE : This cohort study . Patients participate interview 30-45 minute baseline , 6 month , 1 2 year . Patients follow annually least 5 year . PROJECTED ACCRUAL : A total 1,296 patient accrue study within 18-24 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary adenocarcinoma breast Operable disease Invasive unilateral tumor No 20 week since diagnosis T14 ( tumor size â‰¥ 1 cm ) , N0 , M0 OR T14 , N13 , M0 No prior carcinoma situ , lobular carcinoma situ , ductal carcinoma situ , invasive breast cancer Hormone receptor status : Any estrogen receptor status PATIENT CHARACTERISTICS : Age 65 Sex Female Other No malignancy except patient complete treatment AND consider less 30 % risk recurrence History nonmelanoma skin cancer allow Sufficient cognitive function consent complete interview English Spanish speaking</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>estrogen receptor-negative breast cancer</keyword>
	<keyword>estrogen receptor-positive breast cancer</keyword>
</DOC>